Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Van Poznak

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|September 7, 2001
How are bisphosphonates used today in breast cancer clinical practice?C Van Poznak
Journal of Dental Research|February 15, 2011
Making a case for defining osteonecrosis of the jawC Van Poznak
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Pregnancy after bone marrow transplantationS C Gulati, C Van Poznak
Leukemia & Lymphoma|January 1, 1993
Newer approaches in treating chronic myelogenous leukemiaS C Gulati, R Lemoli, C Van Poznak
Stem Cells (Dayton, Ohio)|January 1, 1993
GM-CSF as an adjunct to autologous bone marrow transplantationS Gulati, C Bennett, J Phillips, et al.
Current Cancer Drug Targets|September 11, 2008
The heat shock protein 90 chaperone complex: an evolving therapeutic targetM F Barginear, C Van Poznak, N Rosen, et al.
Journal of Clinical Pathology|January 6, 2006
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumoursC Van Poznak, S S Cross, M Saggese, et al.
Bone|January 1, 2018
Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitisJ G Messer, J L Mendieta Calle, J M Jiron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Bone health in cancer: ESMO Clinical Practice GuidelinesR Coleman, P Hadji, J-J Body, et al.
Breast Cancer Research and Treatment|August 21, 2001
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trialC Van Poznak, A D Seidman, M M Reidenberg, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|September 7, 2001
How are bisphosphonates used today in breast cancer clinical practice?C Van Poznak
Journal of Dental Research|February 15, 2011
Making a case for defining osteonecrosis of the jawC Van Poznak
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Pregnancy after bone marrow transplantationS C Gulati, C Van Poznak
Leukemia & Lymphoma|January 1, 1993
Newer approaches in treating chronic myelogenous leukemiaS C Gulati, R Lemoli, C Van Poznak
Stem Cells (Dayton, Ohio)|January 1, 1993
GM-CSF as an adjunct to autologous bone marrow transplantationS Gulati, C Bennett, J Phillips, et al.
Current Cancer Drug Targets|September 11, 2008
The heat shock protein 90 chaperone complex: an evolving therapeutic targetM F Barginear, C Van Poznak, N Rosen, et al.
Journal of Clinical Pathology|January 6, 2006
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumoursC Van Poznak, S S Cross, M Saggese, et al.
Bone|January 1, 2018
Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitisJ G Messer, J L Mendieta Calle, J M Jiron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Bone health in cancer: ESMO Clinical Practice GuidelinesR Coleman, P Hadji, J-J Body, et al.
Breast Cancer Research and Treatment|August 21, 2001
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trialC Van Poznak, A D Seidman, M M Reidenberg, et al.
Pageof 2